Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharma Gets A Friendly Bill: Proposal Would Cut Medicare Rx Copays

Executive Summary

A bill being sponsored by Sen. Kay Hutchison, R-Tex., aims to demonstrate that reducing Medicare beneficiaries' cost sharing for prescriptions will increase their adherence to medication therapy

You may also be interested in...



Value-Based Insurance In Public Plan Could Change Approach To Rx Copays

Should the public plan option remain part of a final health care reform package, there is one line in the House version of the bill that could transform the insurance industry's approach to patient copayments for drugs

Value-Based Insurance In Public Plan Could Change Approach To Rx Copays

Should the public plan option remain part of a final health care reform package, there is one line in the House version of the bill that could transform the insurance industry's approach to patient copayments for drugs

Value-Based Insurance In Public Plan Could Change Approach To Rx Copays

House health care reform bill would introduce the concept of value-based purchasing into the proposed public plan option.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel